Introduction
============

Mast cells are immune cells implicated in various inflammatory diseases. Since several original studies by [@B30], [@B29], the role of meningeal mast cells as triggers of migraine attacks was further explored by others, showing the pro-nociceptive role of mast cell derived pro-inflammatory cytokines/chemokines ([@B26]; [@B15]; [@B3]; [@B8]). We recently showed that serotonin appeared to be the most important neurotransmitter released by degranulated dural mast cells to activate peripheral meningeal nerve fibers ([@B14]). Despite several potential candidates, it remains, however, unclear which signal or chemical agent initially triggers the activation of meningeal mast cells.

In the frame of the current Research Topic, we published a recent study showing that extracellular ATP acts through the P2X7 subtype of purinergic receptors on meningeal mast cells, leading to both mast cell activation and degranulation ([@B21]). Similar results were found also in human mast cells line ([@B31]). Based on these findings, we hypothesized that this mast-cell based mechanism can indirectly contribute to ATP-induced activation of meningeal afferents. Notably, it is well established that ATP directly excites trigeminal nerve terminals ([@B37]; [@B34]; [@B35]), mainly via P2X3 receptors ([@B34]). Thus, ATP potentially may have a dual complementary migraine pain promoting effect. Given a plethora of pro-inflammatory and pro-nociceptive substances released from active mast cells ([@B8]) these data suggest that ATP-driven mechanisms might significantly contribute both to meningeal neuroinflammation and to prolonged pain in migraine.

Here, we set out to differentiate the indirect, mast cell-mediated, and direct actions of ATP on meningeal afferents in isolated mouse hemiskull preparations, in mice deficient of mast cells. Our data highlight the importance of ATP driven mast cell degranulation in the aggravation of nociceptive firing in migraine pain.

Materials and Methods
=====================

Animals
-------

Experiments were performed on 10--12-week-old male WT C57BL/6J and C57BL/6J-KitW-v/J mice provided by the Animal Facilities of the University of Eastern Finland (UEF). All procedures were approved by the Committee for the Welfare of Laboratory Animals of the University of Eastern Finland and the Provincial Government of Kuopio. Experiments were conducted according to the European Community Council guidelines (Directives 86/609/EEC). All efforts were made to minimize the number of animals used and their suffering.

Toluidine Blue Staining of Meningeal Mast Cells
-----------------------------------------------

Toluidine Blue staining was used to identify mast cells in meningeal tissues as previously described by [@B28] and [@B21]. In short, the brains were carefully removed from the hemiskulls leaving the meninges intact on bone tissue. The hemiskulls were filled with artificial cerebrospinal fluid (ACSF) (in mM): NaCl 115, KCl 3, CaCl2 2, MgCl2 1, NaH2PO4 1, NaHCO3 25, glucose 11) for 10 min (room temperature) and oxygenated with 95% O2/ 5% CO2. The hemiskulls were then transferred to 4% paraformaldehyde and fixed overnight at 4°C followed by three washes with phosphate buffered saline (PBS). Meningeal tissues were dissected from hemiskulls and placed on glass slides (Polysine^®^ Thermo-Scientific, United States) for staining with Toluidine Blue ([@B15]; [@B14]). Images were acquired with an Olympus AX-TFSM microscope (Olympus, Japan).

Electrophysiology
-----------------

Isolated whole-mount mouse hemiskulls were used for spike recordings as previously described ([@B36]; [@B14]; [@B18]). In short, hemiskulls were cleaned from cranial muscles, keeping the dura mater with meningeal nerves and vessels intact. The main meningeal branch of the trigeminal nerve was cleaned from surrounding tissue, cut and placed inside the glass electrode filled with the ACSF. All recordings of electrical activity from trigeminal nerves were performed from hemiskull preparations continuously perfused by ACSF oxygenated with 95% O2/ 5% CO2. Trigeminal nerve spiking activity was registered using DAM80 amplifier (World Precision Instruments, Sarasota, FL, United States). Electrical signals were digitized using a NI PCI6221 board (National Instruments, United States) stored on a PC for off-line analysis. Signals were visualized by WinEDR v.3.2.7 software (University of Strathclyde, Glasgow, United Kingdom) and analyzed with Matlab-based software ([@B36]). All agonists and the antagonist of 5-HT3 receptors (ATP from Sigma-Aldrich, Germany and serotonin and MDL-7222 from Tocris Bioscience, United Kingdom) were prepared immediately before usage and were applied to the receptive fields in meninges by fast perfusion (7 ml/min). ATP and serotonin were dissolved in water, while MDL-7222 was first dissolved in DMSO (stock concentration 30 mM) and then diluted to a final concentration of 10 μM in the basic solution.

Statistical Analysis
--------------------

Experimental data were analyzed using Matlab (MathWorks, Inc., United States). Data are presented as mean ± SEM (standard error of mean). The data were analyzed using Student's paired *t*-test and Mann--Whitney *U*-test when appropriate, the differences accepted significant at *p* ≤ 0.05.

Results
=======

ATP Induced Activation of Meningeal Afferents Reduced in Mast Cells Deficient Mice
----------------------------------------------------------------------------------

We first verified that the mast cell deficient animals were indeed devoid of mast cells. As demonstrated in [Figures 1A,C](#F1){ref-type="fig"},

![ATP induced meningeal firing was significantly reduced in KO mice compared to WT mice and in the presence of the 5-HT3 antagonist MDL-7222. Toluidine Blue staining of meningeal tissue in the WT **(A)** and KO **(C)** mice. **(A)** Toluidine Blue-stained mast cells are shown along the middle meningeal artery (arrows) in the dura mater. **(C)** KO mice show no Toluidine Blue stained cells. **(B)** Representative traces of nociceptive firing recorded from trigeminal nerve fibers in WT and KO mice, respectively, before and after application of 100 μM ATP. **(D)** The time-course of nociceptive firing during application of 100 μM ATP in the WT (black circles, *n* = 6), KO (white circles, *n* = 8) mice, and 100 μM ATP in the presence of 10 μM MDL-7222 in WT mice (gray circles, *n* = 7). Each point represents a mean spike frequency for 2 min of recording. Mean ± SEM, nerve activation levels compared to the baseline using the Student's paired *t*-test, \**p* \< 0.05.](fncel-13-00195-g001){#F1}

where WT meninges contained a vast amount of mast cells, there were no mast cells in the meninges of C57BL/6J-KitW-v/J mice (KO mice).

The pro-nociceptive action of ATP on trigeminal meningeal nerve fibers was electrophysiologically recorded in WT and KO mice. The baseline frequency of meningeal spikes (measured during 2 min before ATP application) was not significantly different in the two groups (27.7 ± 14.8 spikes in the WT, *n* = 6 versus 57.0 ± 29.9 spikes in KO mice, *n* = 8, *p* = 0.322). The application of ATP (100 μM) via rapid perfusion produced a pronounced firing in nerve fibers in both groups of mice ([Figure 1B](#F1){ref-type="fig"}). In WT mice, the frequency of nociceptive spikes after application of ATP increased from the resting value of 27.7 spikes to 400.2 ± 169.1 spikes 6 min after ATP application (*p* = 0.105 as compared to baseline activity, *n* = 6) and to 679.2 ± 185.1 spikes 8 min after ATP application (*p* = 0.024, *n* = 6). In sharp contrast, in KO animals, ATP increased spiking activity from the resting value of 57.0 spikes only to 111 ± 35.5 spikes (*p* = 0.034, *n* = 8) by 6 min and to 199 ± 81.2 spikes (*p* = 0.057, *n* = 8) by 8 min. The detailed time-course of ATP action in WT and KO mice is shown in [Figure 1D](#F1){ref-type="fig"}. Comparative analysis indicated that during the maximal effect (6--8 min of ATP action) the spike frequency in KO mice was significantly lower (*p* = 0.02) compared to the WT mice ([Figure 1D](#F1){ref-type="fig"}).

MDL-7222 Inhibits ATP Mediated Nociceptive Firing
-------------------------------------------------

We recently showed that ATP efficiently promoted the degranulation of meningeal mast cells ([@B21]), a process which is associated with the release of multiple active mediators including serotonin. Endogenous serotonin derived from dural mast cells is a likely candidate to excite nerve fibers as it strongly promotes firing of rat meningeal afferents mainly via neuronal ligand-gated 5-HT3 receptors ([@B14]). Therefore, we next investigated the hypothesis that the part of the pro-nociceptive effect of ATP was mediated by endogenous serotonin via 5-HT3 receptors. To this end, we performed experiments where ATP was applied together with the 5-HT3 receptor antagonist MDL-7222. In the presence of this 5-HT3 blocker, ATP (100 μM) was still able to increase the frequency of meningeal spikes from 6.4 ± 2.8 spikes to 160.3 ± 49.9 (*p* = 0.027, *n* = 7) by 6 min, and to 235.9 ± 71 spikes (*p* = 0.023, *n* = 7) by 8 min. However, this effect was significantly (*p* = 0.035) weaker than the peak frequency induced by ATP alone (679.2 ± 185.1 spikes by 8 min, *p* = 0.024, [Figure 1D](#F1){ref-type="fig"}).

Serotonin Induces Nociceptive Firing via 5-HT3 Receptors
--------------------------------------------------------

In order to confirm that low concentrations of serotonin close to physiological levels of this monoamine ([@B19]; [@B9]) are active in mice, we applied this monoamine to mouse meninges.

Application of 2 μM of serotonin increased spiking activity of trigeminal nerves in WT mice from 13 ± 4.7 spikes to 89.4 ± 15.1 spikes by 16 min (*p* = 0.002 as compared to baseline activity) and then to 92.4 ± 25.6 spikes by 18 min (*p* = 0.015) after serotonin application (*n* = 7, [Figure 2](#F2){ref-type="fig"}). This excitatory action of serotonin was largely prevented in the presence of the 5-HT3 receptor antagonist MDL-7222 (10 μM) down to 36.6 ± 13.1 spikes by 16 min (*p* = 0.057, *n* = 7, [Figure 2](#F2){ref-type="fig"}) and 41.3 ± 16.3 spikes by 18 min after serotonin applied together with MDL-7222 (*p* = 0.084, *n* = 7, [Figure 2](#F2){ref-type="fig"}).

![Serotonin induced nociceptive firing and the inhibitory effect of 5-HT3 antagonist MDL-7222 on serotonin-induced activation of meningeal afferents. The time-course of nociceptive firing before and after application of 2 μM serotonin (black circles) and 2 μM serotonin in the presence of 10 μM MDL-7222 (white circles; *n* = 7 in both groups). Each point represents the mean spike frequency of a 2 min recording period. Mean ± SEM, Student's paired *t*-test, \**p* \< 0.05.](fncel-13-00195-g002){#F2}

Comparison of the spike frequency in the period of maximal serotonin-induced activity (14--18 min) showed that the number of spikes was significantly weaker when this agonist was applied together with MDL-7222 (*p* = 0.038, *n* = 7).

Spectral Analysis of the Pro-nociceptive Effect of ATP
------------------------------------------------------

To compare the functional sequences of ATP induced signaling in the presence and absence of mast cells, we performed spectral analysis of firing activity in the meningeal nerves, which normally sends this information to the second order brainstem neurons ([@B1]).

[Figures 3A,B](#F3){ref-type="fig"} show that the pro-nociceptive effect of ATP in WT mice was characterized by high-frequency discharges. Notably, the spectral analysis revealed that in the WT mice the activity peaked at 10 Hz, which is sufficient for the temporal summation of excitatory signals at the level of secondary nociceptive neurons ([@B36]). In contrast, in KO mice, spectral analysis indicated a prevailing activity at 0.6 Hz ([Figure 3C](#F3){ref-type="fig"}). Similar results were obtained also in the presence of MDL-7222 ([Figure 3D](#F3){ref-type="fig"}). Thus, in the absence of mast cells, and when the action of serotonin was blocked, ATP-induced high frequency events were significantly reduced.

![ATP induced high-frequency discharges are reduced in KO mice and in the presence of MDL-7222. **(A)** Heat maps during application of 100 μM ATP in WT (control and in the presence of MDL-7222) and in KO mice. **(B)** Mean interspike intervals during application of 100 μM ATP in WT mice (*n* = 6). **(C)** Mean interspike intervals in control (black) and after application of 100 μM ATP in KO (*n* = 8). **(D)** Mean interspike intervals during application of 100 μM ATP in presence of MDL-7222 in WT (*n* = 7).](fncel-13-00195-g003){#F3}

Discussion
==========

Here, we demonstrate for the first time the potent excitatory action of extracellular ATP on nociceptive firing of mouse meningeal afferents implicated in generation of migraine pain and the key role of mast cells in this phenomenon.

Despite the high prevalence of migraine, the mechanisms of pain generation in this common disorder have not been fully discovered. The trigeminovascular system of the meninges comprising trigeminal nerve fibers densely innervating dura mater blood vessels, is a well-recognized origin site of migraine pain ([@B17]; [@B22]; [@B20]; [@B25]; [@B36]).

Recent evidence also suggests an important role for meningeal mast cells in triggering migraine pain. Thus, mast cells are densely present in meningeal tissues, located adjacent to both nerves and vessels ([@B30], [@B29]; [@B15]). The contact between mast cells and nerve endings forms a neuro-immune synapse where active substances released by mast cells can activate neighboring nociceptive fibers and compounds released from active fibers, in turn, can degranulate mast cells ([@B10]). There is a long list of active substances, which can take part in the crosstalk between neurons and mast cells. Thus, degranulation of mast cells leads to release of multiple pro-inflammatory substances including enzymes, neurotrophic factors, pro-inflammatory cytokines, histamine and serotonin ([@B33]; [@B8]). Degranulation of dural mast cells can strongly activate meningeal nerve fibers ([@B15]; [@B14]). Interestingly, we found that histamine is weak in excitation of meningeal nerve terminals ([@B14], see also [@B27]). In contrast, serotonin is a powerful inducer of nociceptive firing in meningeal afferents, operating via ligand-gated 5-HT3 receptors ([@B14]).

One of the endogenous substances, which can activate meningeal afferents, is extracellular ATP, a powerful pro-nociceptive and pro-inflammatory agent ([@B12]; [@B6]). The purinergic hypothesis of migraine, suggesting an important role of ATP in migraine pathophysiology, was first proposed by [@B4]. We previously showed in rats, that ATP induced nociceptive firing in trigeminal nerves, through ATP-gated P2X3 receptors ([@B34]; [@B35]). The other study showed that dural topical application of ATP activated more than half of A-delta and C-fibers ([@B37]). In the current study, we also found that ATP produced a huge (24.6-fold) activation of meningeal trigeminal nerve fibers in mice.

Besides this direct excitatory action on nerve terminals, extracellular ATP is also known as a substance triggering mast cell degranulation ([@B31]; [@B21]). Here, we tested the hypothesis that this concomitant action of ATP contributes to activation of trigeminal fibers via degranulation of dural mast cells and the release of additional excitatory agents, such as serotonin. To test this hypothesis, we used C57BL/6J-KitW-v/J mice deficient in mast cells and found that mast cell deficient mice were significantly less sensitive to the excitatory action of extracellular ATP suggesting that mast cells provided an additional component for the pro-nociceptive action.

As serotonin is a well-known mast cell mediator stored in granules and easily released upon activation ([@B33]), we tested its action on mouse trigeminal afferents. We found that concentrations as low as 2 μM of this biogenic amine are able to excite nerve terminals similar to ATP. Notably, like in rats ([@B14]), this effect of serotonin was antagonized by the specific 5-HT3 antagonist MDL-7222 demonstrating the role of the ligand-gated 5-HT3 receptor as a main target of serotonin.

Moreover, when testing the action of ATP in WT mice, ATP-induced firing was also reduced in the presence of MDL-7222 suggesting that the action of ATP is partially mediated by 5-HT3 receptors. It is worth noting that serotonin can promote release of the migraine mediator CGRP ([@B14]) and contributes to meningeal neuroinflammation ([@B7]) which can be a reason for long-lasting pain in migraine. Thus, serotonin can be considered as the endogenous amplifier of purinergic nociception in meninges. On the other hand, at the level of 'postsynaptic' neuronal membrane, there could be the inhibitory interactions between 5-HT3 and P2X channels ([@B2]), which are most significant at high agonist concentrations. This negative mechanism can limit an excessive excitation of afferents when the high level of ATP and serotonin are co-released. ATP-induced firing discharges around 10 Hz detected in the WT and missing in KO mice and in the presence of MDL-7222 may be important for the nociceptive traffic amplification at the level of second order neurons via temporal summation of input signals in the excitatory synapses in the brainstem ([@B36]).

In summary, we report that extracellular ATP, a powerful pro-nociceptive agent, which can be released during a migraine attack ([@B13]), stimulates nociceptive firing in trigeminal afferents via a dual mechanism, including degranulation of resident mast cells and by the direct excitatory action on nerve terminals. ATP can be released from multiple cellular sources including astrocytes, neurons, platelets, and endothelial cells, primarily via exocytosis and/or pannexin/connexin hemichannels ([@B24]; [@B23]; [@B16]). Notably, ATP release could be enhanced in migraine-associated conditions such as shear stress and hypo-osmotic cell swelling ([@B32]; [@B5]) and local inflammation ([@B11]). We suggest that ATP-driven mechanisms contribute both to excitation and to meningeal neuroinflammation in the local neuro-immune unit formed by dural mast cells and trigeminal afferent fibers.
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